Regulatory status
Ask whether the product or procedure is approved, licensed, investigational, or offered under a clinical trial in the country where treatment will occur.
Do not confuse clinic registration with product approvalPatients traveling for stem cell or regenerative medicine treatment often face complex decisions about provider quality, regulation, recovery, and what happens if something goes wrong. HYKR Assured is designed to add a defined patient-support layer around eligible treatment journeys—without promising that the treatment itself will work.
HYKR Assured is not insurance and does not certify that a treatment is effective, appropriate, legal, or approved in any jurisdiction. Eligibility and support depend on the provider program, treatment, certificate, clinical review, exclusions, and limits.
Regulatory reality matters. FDA warns that many stem cell and regenerative medicine products marketed for orthopedic, neurologic, chronic pain, anti-aging, and other uses are not FDA-approved. Patients should verify regulatory status and clinical evidence before treatment.
Read FDA guidance →The strongest HYKR positioning is not “stem cells are safe.” It is “if you are considering a regenerative treatment, understand the medical, regulatory, and support questions before you commit.”
Ask whether the product or procedure is approved, licensed, investigational, or offered under a clinical trial in the country where treatment will occur.
Do not confuse clinic registration with product approvalUnderstand what cells or biologic product are being used, where they come from, how they are processed, and what quality controls apply.
Source transparency mattersAsk what evidence supports the treatment for your specific condition—not just testimonials, broad wellness claims, or marketing language.
Evidence should match the indicationConfirm the treating physicians, facility licensing, emergency capabilities, and who is medically responsible for follow-up if a complication occurs.
Know who owns the clinical decisionDetermine what monitoring, communication, testing, escalation, and home-country support exist once you leave the treatment destination.
The recovery plan should be writtenUnderstand exactly what the clinic guarantee covers, what HYKR support may add, what is excluded, and which costs remain yours.
Read the certificate before treatmentConfirm treatment details, clinician credentials, regulatory status, and informed-consent documents.
The treatment must fit the HYKR provider program and applicable certificate requirements.
Aftercare+ can help structure communication, check-ins, and documentation after travel.
The issue is clinically reviewed. Lack of treatment benefit by itself is not automatically a covered complication.
When the event qualifies, HYKR can coordinate approved support according to the certificate and program limits.
This distinction is critical. HYKR can support the patient journey and defined complication pathways without claiming that stem cell or regenerative medicine treatments are proven, effective, or approved for a particular disease.
A patient may have multiple forms of protection and still face a gap. This table helps explain where HYKR fits without calling HYKR insurance.
| Protection need | Travel Insurance | Clinic Agreement / Guarantee | HYKR Assured* |
|---|---|---|---|
| Trip cancellation, baggage, travel disruption | Often yes | No | No |
| Guarantee that treatment will improve the underlying condition | No | Marketing varies | No |
| Defined support for eligible post-treatment complications | Often excluded | Provider-specific | Yes, when covered |
| Approved home-country corrective support | Often excluded | Often limited | Selected certificates |
| Structured digital aftercare | No | Varies | Aftercare+ |
| Independent certificate limits and exclusions | Policy-specific | Provider-specific | Yes |
*HYKR Assured is a warranty / patient-support program, not health insurance or traditional travel insurance.
Aftercare+ gives HYKR a strong, credible value proposition in regenerative medicine: not promising a cure, but giving patients structured communication, case coordination, and a clearer pathway if questions or complications arise after treatment.
These boundaries make StemCellWarranty.com more credible and help keep the message focused on patient protection rather than unsupported medical claims.
FDA states that the stem cell products it has approved in the United States are blood-forming stem cell products derived from umbilical cord blood for disorders affecting the hematopoietic system. FDA also warns that many regenerative medicine products marketed for orthopedic, neurologic, chronic pain, cardiovascular, pulmonary, anti-aging, and other uses are unapproved.
Review FDA patient guidanceNo. HYKR Assured is a warranty and patient-support program, not traditional health insurance or travel insurance. Support is governed by the patient’s certificate and provider program.
No. HYKR does not guarantee treatment efficacy, medical improvement, or cure. A lack of expected benefit alone is not automatically a qualifying complication.
No. FDA has warned that many regenerative medicine products marketed for common orthopedic, neurological, pain, anti-aging, and other uses are not FDA-approved. Regulatory status also differs by country, so patients should verify the applicable local rules.
Selected HYKR certificates may include Aftercare+ and approved home-country corrective support when the treatment and event meet the applicable terms, limits, and clinical review requirements.
Not necessarily. FDA specifically warns that registration of a firm or listing of a product does not mean the product is legally marketed or FDA-approved.
This form is designed for patients or referral partners who want to understand HYKR support—not to determine whether a stem cell treatment is medically appropriate.
Tell us where you are considering treatment, the provider, and the proposed regenerative medicine product. HYKR can help explain whether a protection program is available.
StemCellWarranty.com is built to add transparency and patient protection around eligible regenerative medicine travel—without overpromising what the treatment itself can do.